MAPKAP Kinase 2-Deficient Mice Are Resistant to Collagen-Induced Arthritis

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Journal of Immunology

• Publication date

  2006-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.4049/jimmunol.177.3.1913PMID 16849504
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• New drugs for rheumatoid arthritis [6] (multiple letters)

  2004cited by this paper
• Synergistic effect on the attenuation of collagen induced arthritis in tumor necrosis factor receptor I (TNFRI) and interleukin 6 double knockout mice.

  2003cited by this paper
• Evolving concepts of rheumatoid arthritis

  2003cited by this paper
• MK2 Targets AU-rich Elements and Regulates Biosynthesis of Tumor Necrosis Factor and Interleukin-6 Independently at Different Post-transcriptional Levels*

  2002cited by this paper
• Therapeutic benefit of blocking interleukin-6 activity with an anti-interleukin-6 receptor monoclonal antibody in rheumatoid arthritis: a randomized, double-blind, placebo-controlled, dose-escalation trial.

  2002cited by this paper
• Distinct Cellular Functions of MK2

  2002cited by this paper
• Abnormal Migration Phenotype of Mitogen-Activated Protein Kinase-Activated Protein Kinase 2−/− Neutrophils in Zigmond Chambers Containing Formyl-Methionyl-Leucyl-Phenylalanine Gradients1

  2001cited by this paper
• MAPKAP kinase 2 is essential for LPS-induced TNF-α biosynthesis

  1999cited by this paper
• The p38 MAP kinase pathway signals for cytokine‐induced mRNA stabilization via MAP kinase‐activated protein kinase 2 and an AU‐rich region‐targeted mechanism

  1999cited by this paper
• Delayed onset and reduced severity of collagen-induced arthritis in interleukin-6-deficient mice.

  1999cited by this paper
• Interleukin 6 Is Required for the Development of Collagen-induced Arthritis

  1998cited by this paper
• Attenuation of collagen-induced arthritis in 55-kDa TNF receptor type 1 (TNFR1)-IgG1-treated and TNFR1-deficient mice.

  1996cited by this paper
• AU-rich elements: characterization and importance in mRNA degradation.

  1995cited by this paper
• A novel kinase cascade triggered by stress and heat shock that stimulates MAPKAP kinase-2 and phosphorylation of the small heat shock proteins.

  1994cited by this paper
• MAPKAP kinase‐2; a novel protein kinase activated by mitogen‐activated protein kinase.

  1992cited by this paper
• Endotoxin-responsive sequences control cachectin/tumor necrosis factor biosynthesis at the translational level [published erratum appears in J Exp Med 1990 Mar 1;171(3):971-2]

  1990cited by this paper
• A conserved AU sequence from the 3' untranslated region of GM-CSF mRNA mediates selective mRNA degradation.

  1986cited by this paper
• Identification of a common nucleotide sequence in the 3'-untranslated region of mRNA molecules specifying inflammatory mediators.

  1986cited by this paper
• Type II collagen-induced arthritis in mice. II. Passive transfer and suppression by intravenous injection of anti-type II collagen antibody or free native type II collagen.

  1984cited by this paper
• [Rheumatoid arthritis].

  1983cited by this paper
• Type II collagen-induced arthritis in mice. I. Major histocompatibility complex (I region) linkage and antibody correlates

  1981cited by this paper
• Autoimmunity to type II collagen an experimental model of arthritis

  1977cited by this paper

• Targeted degradation of MK2 is insufficient to block inflammatory cytokine production in human cells due to cooperativity with MK3 and MK5

  2026cites this paper
• Multi-omics and experimental validation reveal the mechanism of DanxiaTiaoban decoction in treating atherosclerosis.

  2025cites this paper
• MK2 deficiency decreases mortality in male mice during the inflammatory phase after myocardial infarction

  2025cites this paper
• Novel therapies for axial spondyloarthritis and future directions.

  2025cites this paper
• Degradation of MK2 with natural compound andrographolide: a new modality for anti-inflammatory therapy.

  2023cites this paper
• Revisiting p38 Mitogen-Activated Protein Kinases (MAPK) in Inflammatory Arthritis: A Narrative of the Emergence of MAPK-Activated Protein Kinase Inhibitors (MK2i)

  2023influential citation
• Discovery of CC-99677, a Selective Targeted Covalent MAPKAPK2 (MK2) Inhibitor for Autoimmune Disorders.

  2022cites this paper
• Novel therapies in axial spondyloarthritis.

  2022cites this paper
• CC-99677, a novel, oral, selective covalent MK2 inhibitor, sustainably reduces pro-inflammatory cytokine production

  2022cites this paper
• MAPK activated kinase 2 inhibition shifts the chemokine signature in arthritis synovial fluid mononuclear cells from CXCR3 to CXCR2.

  2022cites this paper
• Identification and Validation of Hub Genes in Acute Pancreatitis and Hypertriglyceridemia

  2022cites this paper
• DMSO_A_349528 559..577

  2022cites this paper
• Lessons From the Success and Failure of Targeted Drugs for Rheumatoid Arthritis: Perspectives for Effective Basic and Translational Research

  2022cites this paper
• Effects of Pereskia aculeate Miller Petroleum Ether Extract on Complete Freund’s Adjuvant-Induced Rheumatoid Arthritis in Rats and its Potential Molecular Mechanisms

  2022cites this paper
• Targeting MAPAKAP2(MK2) to combat inflammation by avoiding the differential regulation of anti-inflammatory genes by p38 MAPK inhibitors

  2022cites this paper
• Mitogen‐activated protein kinase‐activated protein kinase‐2 (MK2) and its role in cell survival, inflammatory signaling, and migration in promoting cancer

  2021cites this paper
• Mitogen and Stress-Activated Kinases 1 and 2 Mediate Endothelial Dysfunction

  2020cites this paper
• Targeting MAPK/MKP Signaling as a Therapeutic Axis in Periodontal Disease

  2020cites this paper
• Novel Therapeutic Potential of Mitogen-Activated Protein Kinase Activated Protein Kinase 2 (MK2) in Chronic Airway Inflammatory Disorders.

  2019cites this paper
• Selective inhibition of the p38α MAPK–MK2 axis inhibits inflammatory cues including inflammasome priming signals

  2018cites this paper
• Sec6 enhances cell migration and suppresses apoptosis by elevating the phosphorylation of p38 MAPK, MK2, and HSP27.

  2018cites this paper
• Lemon-Peel extract ameliorates rheumatoid arthritis by reducing xanthine oxidase and inflammatory cytokine levels

  2018cites this paper
• MK2 mediates macrophage activation and acute lung injury by regulating let-7e miRNA.

  2018cites this paper
• A Role for MK2 in Enhancing Neutrophil-Derived ROS Production and Aggravating Liver Ischemia/Reperfusion Injury

  2018cites this paper
• Mitogen-Activated Protein Kinase- Activated Protein Kinase 2 Deficiency Reduces Insulin Sensitivity in High- Fat Diet-Fed Mice Without Affecting Adipose Tissue Inflammation

  2018cites this paper
• Synergistic effect of glucosamine and vitamin E against experimental rheumatoid arthritis in neonatal rats.

  2018cites this paper
• Pharmacological and genetic inhibition of downstream targets of p38 MAPK in experimental nephrotic syndrome.

  2018cites this paper
• Biological functions and role of mitogen-activated protein kinase activated protein kinase 2 (MK2) in inflammatory diseases

  2017cites this paper
• Collagen-binding nanoparticles for extracellular anti-inflammatory peptide delivery decrease platelet activation, promote endothelial migration, and suppress inflammation.

  2017cites this paper
• Oxidized LDL-induced JAB1 influences NF-κB independent inflammatory signaling in human macrophages during foam cell formation

  2017influential citation
• Building molecules for the modulation of age-related diseases

  2016cites this paper
• MK2 inhibitor reduces alkali burn-induced inflammation in rat cornea

  2016cites this paper
• Pivotal Role of Mitogen-Activated Protein Kinase-Activated Protein Kinase 2 in Inflammatory Pulmonary Diseases.

  2016cites this paper
• Suppression of the senescence-associated secretory phenotype (SASP) in human fibroblasts using small molecule p38 and MK2 inhibitors

  2016cites this paper
• Selective suppression of the α isoform of p38 MAPK rescues late-stage tau pathology

  2016cites this paper
• Control of IL-17 receptor signaling and tissue inflammation by the p38α–MKP-1 signaling axis in a mouse model of multiple sclerosis

  2015cites this paper
• Roles of p38α mitogen‐activated protein kinase in mouse models of inflammatory diseases and cancer

  2015cites this paper
• Design, synthesis, and biological evaluation of aminopyrazine derivatives as inhibitors of mitogen-activated protein kinase-activated protein kinase 2 (MK-2).

  2015cites this paper
• MAP Kinase Cascades in Antigen Receptor Signaling and Physiology.

  2015cites this paper
• Suppression of the senescence-associated secretory phenotype (SASP) in human fibroblasts using small molecule inhibitors of p38 MAP kinase and MK2

  2015cites this paper
• Regulation of Inflammatory Cytokine Production by MKP‐5 in Macrophages

  2015cites this paper
• Hypoxia-Mediated Soluble Fms-Like Tyrosine Kinase 1 Increase Is Not Attenuated in Interleukin 6-Deficient Mice

  2015cites this paper
• Discovery and characterization of MAPK-activated protein kinase-2 prevention of activation inhibitors.

  2015cites this paper
• Microwave-Assisted Synthesis of a MK2 Inhibitor by Suzuki-Miyaura Coupling for Study in Werner Syndrome Cells

  2015cites this paper
• The expression of HLA-B27 modulates intracellular signaling in human monocytic macrophages

  2014cites this paper
• University of Groningen Mitogen-Activated Protein Kinase-Activated Protein Kinase 2 Deficiency Reduces Insulin Sensitivity in High-Fat Diet-Fed Mice

  2014cites this paper
• Systemic cytokine expression and endothelial dysfunction : insights from innate immune models of protein phosphorylation

  2014cites this paper
• Mitogen-Activated Protein Kinase–Activated Protein Kinase 2 in Neuroinflammation, Heat Shock Protein 27 Phosphorylation, and Cell Cycle: Role and Targeting

  2014cites this paper
• Microwave-assisted Synthesis of Inhibitors of MK2 for Targeting p38 MAP Kinase Signalling in Werner Syndrome Cells

  2014cites this paper
• Mitogen-activated Protein Kinase Phosphatases in Inflammation and as Anti-inflammatory Drug Targets

  2014cites this paper
• The Role of Mitogen Activated Protein Kinase-Activated Protein Kinase 2 in Proliferation and Migration of Gastroesophageal Cancer Cells

  2014cites this paper
• MMI-0100 inhibits cardiac fibrosis in myocardial infarction by direct actions on cardiomyocytes and fibroblasts via MK2 inhibition.

  2014cites this paper
• Mitogen-Activated Protein Kinase-Activated Protein Kinase 2 Deficiency Reduces Insulin Sensitivity in High-Fat Diet-Fed Mice

  2014cites this paper
• Discovery of a novel series of potent MK2 non-ATP competitive inhibitors using 1,2-substituted azoles as cis-amide isosteres.

  2014cites this paper
• Leptin does not Induce an Inflammatory Response in the Murine Placenta

  2014cites this paper
• Inhibitory effects of intrathecal p38β antisense oligonucleotide on bone cancer pain in rats.

  2014cites this paper
• Alternative p38 MAPKs Are Essential for Collagen‐Induced Arthritis

  2014cites this paper
• MAPKAP kinase 3 suppresses Ifng gene expression and attenuates NK cell cytotoxicity and Th1 CD4 T‐cell development upon influenza A virus infection

  2014cites this paper
• Kinase inhibitors: a new tool for the treatment of rheumatoid arthritis.

  2013cites this paper
• Mitogen-activated protein kinases in innate immunity

  2013cites this paper
• Conformation constraint of anilides enabling the discovery of tricyclic lactams as potent MK2 non-ATP competitive inhibitors.

  2013cites this paper
• The Role of Mitogen-Activated Protein Kinase-Activated Protein Kinases (MAPKAPKs) in Inflammation

  2013cites this paper
• The Emerging Role of p38 Mitogen-Activated Protein Kinase in Multiple Sclerosis and Its Models

  2013cites this paper
• Inhibition of MK2 shows promise for preventing postoperative ileus in mice.

  2013cites this paper
• MAPK-activated protein kinase 2 (MK2) in neuroinflammation, Hsp27 phosphorylation and cell cycle: Role and Targeting

  2013cites this paper
• p38 inhibition and not MK2 inhibition enhances the secretion of chemokines from TNF-α activated rheumatoid arthritis fibroblast-like synoviocytes.

  2013cites this paper
• What goes up must come down: molecular basis of MAPKAP kinase 2/3-dependent regulation of the inflammatory response and its inhibition

  2013cites this paper
• Mitogen‐activated protein kinase 2 regulates physiological and pathological bone turnover

  2013cites this paper
• Endoplasmic reticulum-associated ubiquitin-conjugating enzyme Ube2j1 is a novel substrate of MK2 (MAPKAP kinase-2) involved in MK2-mediated TNFα production.

  2013cites this paper
• Kinase drug discovery--what's next in the field?

  2013cites this paper
• p38 mitogen-activated protein kinase (p38 MAPK)-mediated autoimmunity: lessons to learn from ANCA vasculitis and pemphigus vulgaris.

  2013cites this paper
• The Role of p38 MAPK in the Aetiopathogenesis of Psoriasis and Psoriatic Arthritis

  2013influential citation
• MAPK Usage in Periodontal Disease Progression

  2012cites this paper
• ASC plays a role in the priming phase of the immune response to type II collagen in collagen-induced arthritis

  2012cites this paper
• The p38 MAPK Pathway in Rheumatoid Arthritis: A Sideways Look

  2012cites this paper
• Small-molecule protein and lipid kinase inhibitors in inflammation and specific models for their evaluation.

  2012cites this paper
• Decreased collagen-induced arthritis severity and adaptive immunity in MKK-6-deficient mice.

  2012cites this paper
• A three-step protocol for lead optimization: quick identification of key conformational features and functional groups in the SAR studies of non-ATP competitive MK2 (MAPKAPK2) inhibitors.

  2012cites this paper
• Facile synthesis of tetracyclic azepine and oxazocine derivatives and their potential as MAPKAP-K2 (MK2) inhibitors.

  2012cites this paper
• A Computational Study on Thiourea Analogs as Potent MK-2 Inhibitors

  2012cites this paper
• Discovery of a Potent Dihydrooxadiazole Series of Non-ATP-Competitive MK2 (MAPKAPK2) Inhibitors.

  2012cites this paper
• Mitogen-activated protein kinase-activated protein kinase 2 (MAPKAP-K2) as an antiinflammatory target: discovery and in vivo activity of selective pyrazolo[1,5-a]pyrimidine inhibitors using a focused library and structure-based optimization approach.

  2012cites this paper
• Novel ATP competitive MK2 inhibitors with potent biochemical and cell-based activity throughout the series.

  2011cites this paper
• Discovery of selective and orally available spiro-3-piperidyl ATP-competitive MK2 inhibitors.

  2011cites this paper
• Anti-Inflammatory/Analgesics: An In-Depth Look at p38 MAP Kinases

  2011cites this paper
• Peptide inhibitors of MK2 show promise for inhibition of abdominal adhesions.

  2011cites this paper
• Structure-based lead identification of ATP-competitive MK2 inhibitors.

  2011cites this paper
• Silencing Mitogen-Activated Protein Kinase-Activated Protein Kinase-2 Arrests Inflammatory Bone Loss

  2011cites this paper
• Discovery and Hit-to-Lead Optimization of Non-ATP Competitive MK2 (MAPKAPK2) Inhibitors.

  2011cites this paper
• Mono(2-ethylhexyl) phthalate induces both pro- and anti-inflammatory responses in rat alveolar macrophages through crosstalk between p38, the lipoxygenase pathway and PPARα

  2010cites this paper
• P38 Mitogen-activated Protein Kinase Activity Is Required during Mitosis for Timely Satisfaction of the Mitotic Checkpoint But Not for the Fidelity of Chromosome Segregation

  2010cites this paper
• A multitude of kinases--which are the best targets in treating rheumatoid arthritis?

  2010cites this paper
• In vivo and in vitro SAR of tetracyclic MAPKAP-K2 (MK2) inhibitors. Part I.

  2010cites this paper
• The role of mitogen-activated protein kinase-activated protein kinase 2 in the p38/TNF-alpha pathway of systemic and cutaneous inflammation.

  2010influential citation
• A Benzothiophene Inhibitor of Mitogen-Activated Protein Kinase-Activated Protein Kinase 2 Inhibits Tumor Necrosis Factor α Production and Has Oral Anti-Inflammatory Efficacy in Acute and Chronic Models of Inflammation

  2010cites this paper
• Athletic performance and conformation in Hanoverian warmblood horses

  2010cites this paper
• Novel 3-aminopyrazole inhibitors of MK-2 discovered by scaffold hopping strategy.

  2010cites this paper
• MAPKAP kinases MK2 and MK3 in inflammation: complex regulation of TNF biosynthesis via expression and phosphorylation of tristetraprolin.

  2010cites this paper
• p38gamma mitogen-activated protein kinase suppresses chondrocyte production of MMP-13 in response to catabolic stimulation.

  2010cites this paper
• Intracellular Signaling Pathways in Skin Inflammation and Cancer by Claus Johansen

  2010cites this paper